⚠ Research and educational use only — not for human consumption. Nothing for sale, no dosing advice. PeptideCompare is non-profit and independent.
Database Suppliers Quality & badges Supplier reviews Encyclopedia Articles Calculator
LONGEVITY TOPICS
NAD+ Precursors Sirtuin Activators Senolytics Autophagy Mitochondrial Hormesis
About FAQ Contact Policy
MONOGRAPH No. 009
EVIDENCE BASEStrong
CLASS
Mitochondrial peptide
MW
2174.5 g/mol
ORIGIN
Mitochondrial 12S rRNA
MECHANISM
AMPK activation
EU STATUS
Research only
View prices →
⏳ Anti-Aging & Longevity

MOTS-C — encoded in your mitochondria.

MOTS-C (Mitochondrial Open reading frame of the twelve S rRNA type-c) is a peptide encoded within mitochondrial DNA itself — discovered in 2015. It activates AMPK, improves insulin sensitivity, and supports mitochondrial function. It is one of the few peptides in this category with a natural endogenous origin.

Last reviewed:

Why mitochondrial origin matters

MOTS-C is unusual in that it is not synthesised by nuclear genes but encoded within mitochondrial DNA. It is secreted from mitochondria in response to metabolic stress and acts as a retrograde signal to the nucleus, regulating nuclear gene expression. Serum MOTS-C levels decline with age in humans, making it an interesting longevity research target.

EVIDENCE SUMMARY
STRONG
AMPK activation & insulin sensitivity — Consistent animal data. Improved insulin sensitivity and glucose metabolism in rodent models including type 2 diabetes models.
MODERATE
Age-related decline (human correlation) — Human studies show declining serum MOTS-C with age, correlation with metabolic health markers. Not causal.
LIMITED
Exercise mimetic effects — Animal data suggesting MOTS-C mimics some beneficial effects of exercise training. Human trial data pending.

Molecular information

Molecular formula
C101H152N28O22S2
Molecular weight
2174.5 g/mol

Pharmacokinetics

Half-life (t½)
≈ 1.5 h
Source: Literature estimate (~1–2 h exogenous plasma)

Potency retained over time

Each line is one storage condition: it starts at 100% and falls as potency is lost. Above the dashed 80% line the material is considered reliable — hover for exact values.

Freezer −20 °C
36+ mo
Stable · >95% potency
Fridge 4 °C
4-5 wks
In use · after recon
Room 20 °C
5-6 days
Avoid · increased loss
Warm 37 °C+
<1 day
Critical · rapid degradation

⚠ Computed from molecular properties (sequence length, cyclisation, residues prone to oxidation or deamidation, light sensitivity), per compound. Indicative only — not lab-measured per batch.

Compare MOTS-C prices across EU suppliers

COA-verified · Multiple EU vendors · Updated monthly

Frequently asked questions

What is MOTS-c?

MOTS-c is a mitochondrial-derived peptide encoded within mitochondrial DNA (12S rRNA) rather than by nuclear genes. It is secreted under metabolic stress and acts as a retrograde signal to the nucleus, activating AMPK.

Why does its mitochondrial origin matter?

Unlike most peptides it is encoded in mitochondrial DNA and signals from the mitochondria to the nucleus to regulate gene expression. Serum levels decline with age, making it a longevity research target.

What does the research show?

There is strong animal evidence for AMPK activation and improved insulin sensitivity, including type 2 diabetes models, moderate human correlation of declining serum MOTS-c with age, and limited animal data suggesting exercise-mimetic effects.

Is MOTS-c an exercise mimetic?

Animal data suggest it mimics some beneficial effects of exercise training, but human trial data are pending, so this remains preliminary.

Does MOTS-c decline with age?

Human studies show serum MOTS-c declining with age and correlating with metabolic health markers, though this is correlational and not established as causal.

Is MOTS-c legal in the EU?

It is sold as a research compound for laboratory use only.

References

  1. The paper that identified MOTS-c: a 16-amino-acid peptide encoded inside the mitochondrial 12S rRNA gene, acting through the folate cycle and AMPK. The metabolic findings — improved insulin sensitivity, less weight gain on a high-fat diet — are in mice, not people. Lee C, et al. Cell Metab. 2015;21(3):443–454. PMC4350682
  2. Follow-up work in mice mapping which plasma metabolite pathways shift after MOTS-c injection. Useful for mechanism, but note what is still missing across this whole literature: no study of administered MOTS-c in humans has reported pharmacokinetics or outcomes. Kim SJ, et al. Physiol Rep. 2019;7(13):e14171. PMC6640593

Related guides

PeptideCompare AssistantOnline · replies instantly
Hi! I help you quickly find the right page — about legality, COAs, badges or suppliers. No price advice, no dosing.
Try a question
Find a supplier Questions about a peptide? Read our articles Compare prices
Navigation assistant · no medical advice